Thursday, May 23, 2019
engineered enzymes for better healthcare

Phenylketonuria (PKU) is a result of an enzyme defect that prevents metabolism of the amino acid phenylalanine and occurs in approximately 1 in every 15,000 (1 in 4,500 in Ireland). PKU can cause mental and motor retardation, poor growth and seizures. With early detection and proper dietary treatment growth and development of infants with PKU should be normal.

Product Info



Disorders of Amino Acid Metabolism

PKU        Phenylketonuria

MSUD     Maple Syrup Urine Disease

HCY        Homocystinuria

TYR-I      Tyrosinaemia Type-I

Language Selection


Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…


Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…


UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…